OTC Antacid/Aspirin Bleeding Risk Raises Concerns At CDER
This article was originally published in The Tan Sheet
Executive Summary
CDER publishes a Drug Safety Communication, a consumer announcement and a MedWatch notice warning about the risk of serious bleeding when using OTC aspirin-containing antacid products.
You may also be interested in...
What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?
Nonprescription Drug and the Drug Safety and Risk Management advisory committees jointly vote 15-5 that combining antacid with aspirin, acetaminophen or other analgesic ingredients is not a combination that should be allowed under an OTC monograph.
What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?
Nonprescription Drug and the Drug Safety and Risk Management advisory committees jointly vote 15-5 that combining antacid with aspirin, acetaminophen or other analgesic ingredients is not a combination that should be allowed under an OTC monograph.
Safety Review For Upset Stomach, Hangover OTCs Reconsiders Science
The US Nonprescription Drugs and Drug Safety and Risk Management advisory committees will discuss the safety of using OTC analgesic combination products for upset stomach and hangover even though Drug Facts labels already warn about the risk of serious bleeding.